14.1
İnsan Mikrobiyotasına Giriş
Mikroorganizmalar, ağız, burun yolları, boğaz, mide, bağırsaklar, ürogenital yol ve cilt gibi insan vücudunun çeşitli bölgelerini kolonileştirir. Topl…
İnsan vücudu, özellikle bakteriler olmak üzere çok sayıda mikroba ev sahipliği yapar; bunlar cilt, ağız, bağırsak ve ürogenital yol dahil olmak üzere vücudun birçok bölgesinde bulunur.
Bu mikroplar birlikte, vücuttaki temel işlevleri destekleyen insan mikrobiyotasını oluşturur.
Bu mikropların bir kısmı, uzun süreli, istikrarlı popülasyonlar olan yerleşik mikrobiyotayı oluştururken, geçici mikrobiyota sadece kısa süreli olarak mevcuttur.
Mikrobial kolonizasyon doğumda başlar. Bir kişi büyüdükçe, diyet, yaş, çevre ve antibiyotik kullanımı gibi faktörler mikrobiyal toplulukların çeşitliliğini ve istikrarını etkiler.
Ayrıca, sıcaklık, pH, oksijen seviyeleri ve vücut salgıları mikrobiyal büyümeyi etkiler.
Mikrobiyal antagonizm olarak bilinen bir süreç sayesinde, normal mikrobiyota konakçını fiziksel olarak bağlayıcı bölgeleri işgal ederek ve besinleri tüketerek koruyabilir; böylece istilacı patojenleri geride bırakır.
Örneğin, bağırsaktaki mikroorganizmalar vitaminleri sentezleyerek ve bakteriyosin üretimiyle patojenleri baskılayarak sağlığı destekler.
View the full transcript and gain access to JoVE Core videos
Q1: What is the human microbiota and where does it live in the body?
The human microbiota is a community of microbes, primarily bacteria, that inhabit multiple body regions including the skin, mouth, gut, and urogenital tract. Together, these microbial populations support key functions essential for health. The total number of microbial cells ranges from 10¹³ to 10¹⁴, comparable to or exceeding human somatic cells, making humans supraorganisms dependent on microbial communities.
Q2: How does the human microbiota protect the body from harmful pathogens?
Through microbial antagonism, the normal microbiota protects the host by physically occupying binding sites and consuming nutrients, outcompeting invading pathogens. Gut microorganisms synthesize vitamins and suppress pathogens through bacteriocin production. This protective balance can be disrupted by antibiotics, potentially allowing harmful species like Clostridioides difficile to overgrow.
Q3: What factors influence the diversity and composition of microbial communities during human development?
Microbial colonization begins at birth and is shaped by maternal vaginal flora in vaginal births or skin and environmental microbes in cesarean deliveries. As a person grows, diet, age, environment, and antibiotic use influence microbial diversity and stability. Temperature, pH, oxygen levels, and body secretions also affect microbial growth, with the gut microbiota stabilizing after three years but remaining responsive to environmental influences.
Q4: What are the differences between resident and transient microbiota?
Resident microbiota are long-term, stable populations that establish and persist in specific body sites, forming the core microbial community. Transient microbiota are present only for short durations and do not establish permanent colonization. Both populations contribute to the overall microbiota, but resident microbiota provide consistent protective and metabolic functions.
Q5: How do different types of microbe-host relationships affect human health?
Symbiotic relationships within the microbiota are diverse: commensals benefit without affecting the host, mutualistic microbes offer reciprocal advantages such as E. coli synthesizing essential vitamins, and parasitic organisms harm the host. However, normally benign microbes can become opportunistic pathogens under certain conditions, demonstrating the dynamic nature of host-microbe interactions.
Q6: What role does the microbiota play in human health and disease susceptibility?
The host-microbiome relationship is fundamental to development, immunity, and disease susceptibility. The microbiota functions akin to a vital organ, essential for maintaining health and homeostasis. Understanding the microbiome holds promise for clinical advancements including disease risk biomarkers, tailored microbial therapies, personalized medicine, and custom-designed probiotics.
Q7: How have modern technologies advanced our understanding of microbial diversity in the human body?
Culture-independent methods such as 16S rRNA gene sequencing and metagenomics have revealed extensive microbial diversity and facilitated comparisons across individuals and body sites. These technologies revealed that although species-level composition varies widely, similarities often emerge at higher taxonomic levels. The Human Microbiome Project and global metagenomic initiatives demonstrated that the microbiome's genetic capacity far exceeds the human genome.